
10X Genomics Inc
TXG · NASDAQ · Healthcare / Medical Devices
Price History
Full chartMarket Stats
About
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Company Details
- SectorHealthcare
- IndustryMedical Devices
- CEODr. Serge Saxonov Ph.D.
- Employees1.18K
- Headquarters6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260, USA
- Websitehttps://www.10xgenomics.com
Leadership
- Dr. Serge Saxonov Ph.D.Co-Founder, CEO & Director · b. 1977
- Dr. Benjamin J. Hindson Ph.D.Co-Founder, President, Chief Scientific Officer & Director · b. 1975
- Mr. Adam S. TaichCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer · b. 1975
- Mr. Jim GoodrichChief of Global Operations
- Mr. Michael Schnall-Levin Ph.D.Founding Scientist & CTO
- Ms. Cassie CorneauManager of Investor Relations & Strategic Finance
- Dr. Randy WuGeneral Counsel and Secretary
- Ms. Mennah MoustafaChief Commercial Officer
- Mr. Jens DurruthyAssociate Director of Product Management
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy6
- Buy1
- Hold11
Ownership Breakdown
- Institutions
- 117.64%
- Insiders
- 1.44%
- Retail / Other
- 0.00%
Top Institutional Holders
- FMR Inc17.63M13.53%
- BlackRock Inc10.80M8.29%
- ARK Investment Management LLC10.00M7.68%
- Vanguard Portfolio Management, LLC6.98M5.36%
- Quantinno Capital Management LP5.47M4.20%
- Vanguard Capital Management, LLC5.08M3.90%
- T. Rowe Price Associates, Inc.4.54M3.48%
- Sumitomo Mitsui Trust Group Inc4.19M3.22%
- Amova Asset Management Americas, Inc4.19M3.22%
- Morgan Stanley - Brokerage Accounts3.35M2.57%
- The Goldman Sachs Group Inc3.15M2.42%
- Geode Capital Management, LLC3.08M2.37%
- State Street Corp2.80M2.15%
- Citadel Advisors Llc2.78M2.13%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest3.82M2.93%
- ARK Innovation ETF3.06M2.35%
- iShares Russell 2000 ETF3.03M2.33%
- Vanguard Small Cap Index2.71M2.08%
- T. Rowe Price New Horizons2.65M2.03%
- ARK Genomic Revolution ETF2.46M1.89%
Stock Splits
- Jul 17, 20061:2